Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Number of holders
-
2595
-
Total 13F shares, excl. options
-
1,186,224,948
-
Shares change
-
-10,173,170
-
Total reported value, excl. options
-
$128,344,178,557
-
Value change
-
-$1,087,268,478
-
Put/Call ratio
-
1.17%
-
Number of buys
-
1,378
-
Number of sells
-
-987
-
Price
-
$108.22
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q1 2021
2,790 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q1 2021.
AbbVie Inc. - Common Stock (ABBV) has 2,595 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,186,224,948 shares
of 1,767,364,935 outstanding shares and own 67.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (143,733,946 shares), BlackRock Inc. (126,615,997 shares), STATE STREET CORP (75,495,948 shares), FMR LLC (36,663,803 shares), JPMORGAN CHASE & CO (33,664,795 shares), PRICE T ROWE ASSOCIATES INC /MD/ (32,212,195 shares), GEODE CAPITAL MANAGEMENT, LLC (27,232,599 shares), NORTHERN TRUST CORP (23,727,501 shares), Berkshire Hathaway Inc (22,868,178 shares), and Bank of New York Mellon Corp (20,601,620 shares).
This table shows the top 2595 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.